Entomologists review pros, cons and regulatory issues surrounding new technology that could help halt the spread of diseases such as Zika virus, dengue fever and malaria
Engineered gene drives, which have the potential to spread desirable genes throughout wild populations or to suppress harmful species, have received a lot of recent attention because of their potential to control organisms, such as mosquitoes that carry diseases such as Zika virus, malaria and dengue fever.
At the same time, the recently discovered CRISPR gene editing technology has the potential to create, streamline and improve the development of gene drives.
In a highly innovative and technical review, an entomologist at the University of California, Riverside has examined the different gene drives systems, analyzed the pros and cons of each and applications associated with them, and also surveyed the safety and regulatory issues associated with them.
“Despite all the potential benefits of gene drives, they remain understudied,” said Omar Akbari, an assistant professor of entomology at UC Riverside. “With that in mind, and with advances occurring so quickly, we wanted to step back and take a broad look at what is happening.”
Akbari, who is also a member of UC Riverside’s Center for Disease Vector Research andInstitute for Integrative Genome Biology, is the corresponding author of the piece, “Cheating evolution: engineering gene drives to manipulate the fate of wild populations,” that was just published online in the journal Nature Reviews Genetics. The piece was co-authored by Jackson Champer and Anna Buchman, both post-doctoral students working with Akbari.
The idea of editing the genes of organisms to address biological problems related to public and environmental health has been around for decades. In fact, the authors cite a paper from 1940 and others from the late 1960s that discuss this.
Despite the wide-ranging applicability and importance of gene drives, there has been only modest development in their progress in past decades. Gene drives capable of functioning in wild populations have been created in only a few organisms, including yeast, the fruitfly and two species of mosquitoes.
This is, in part, due to the difficulty of engineering the genomes of organisms. However, recent advancements have provided tools capable of engineering the genomes of diverse species. The most promising of these tools is CRISPR.
Combining gene drives and a tool such as CRISPR may enable the development of novel strategies to reduce or eliminate insect-borne diseases, remove invasive foreign species, and even reverse the development of resistance to insecticides and herbicides, in an economically viable and environmentally friendly manner.
In the paper, the authors focus on several types of gene drives, including homing-based drives, sex-linked meiotic drives, medea and underdominance gene drives. They describe the gene drives based on different attributes, including rate of spread, species specificity, fitness cost, susceptibility to resistance,removability and reversibility.
They also discuss whether the gene drives are classified as ‘modification drive’ types, which are designed to spread through a population carrying desirable traits, or as ‘suppression drive’ types, which have the effect of reducing the population of a target species.
Finally, the authors address safety and regulation. They mention dangers associated with gene drives, including the potential to cause extinctions, to spread outside a geographical area or traverse into another species and the potential misuse to cause economic damage or even bioterrorism.
Learn more: Engineered Gene Drives and the Future
The Latest on: Engineered gene drives
via Google News
The Latest on: Engineered gene drives
- Cancer immunotherapy comes of age and looks for maturityon July 3, 2020 at 2:28 am
As Nature Communications celebrates a 10-year anniversary, the field has witnessed the transition of cancer immunotherapy from a pipe dream to an established powerful cancer treatment modality. Here ...
- Suzuki’s new Across SUV has Toyota Rav4 geneson July 1, 2020 at 5:00 pm
Just like Ford and Volkswagen are teaming up for certain future products such as bakkies and vans, Toyota and Suzuki have been flirting with their own joint ventures, although it’s worth noting that ...
- A New Target for Liver Disease Treatments Identifiedon July 1, 2020 at 8:24 am
An understudied type of liver cell may drive scarring ... In contrast, this gene was not expressed in hepatic stellate cells, giving the investigators a way to distinguish the two cell types. Using ...
- Suzuki reveals new Across SUV with Toyota Rav4 geneson July 1, 2020 at 7:32 am
Nonetheless, the Toyzuki collaboration (or is it Suzota?) has already resulted in a badge-engineered Suzuki Baleno in India, which is called the Toyota Glanza, and a Suzuki-based compact SUV is also ...
- Public biopharmaceutical companies post strong gains in second quarteron June 30, 2020 at 3:48 pm
The share prices of blue-chip biopharmaceutical companies closed out the month on a high note to contribute to their stellar collective performance during the second quarter, with the BioWorld ...
- Who is afraid of genetically modified mosquitoes?on June 24, 2020 at 8:13 pm
Their genomes are changed in a way that does not happen naturally, and in doing so, their natural characteristics are changed and newly engineered ... CRISPR gene-editing and gene-drives are ...
- Are Genetically Engineered Mice The Answer To Combating Lyme Disease?on June 16, 2020 at 12:49 am
So, if mice could be engineered to be resistant to tick-borne ... unworkable unless one of the controversial methods of gene drive were used, involving foreign non-mouse DNA.
- Gene Engineered Subunit Vaccine Market Analysis, Trends and CAGR Projections 2020-2026on June 12, 2020 at 10:58 am
A recent report provides crucial insights along with application based and forecast information in the Global Gene Engineered Subunit Vaccine Market. The report provides a comprehensive analysis of ...
- Regenerative Medicine Gets Weavingon June 5, 2020 at 12:05 am
To mass produce recombinant human collagen (rhCollagen), CollPlant Biotechnologies uses tobacco plants, genetically engineered with the five genes responsible ... that will drive new breakthroughs ...
via Bing News